Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir

AIDS. 2004 Apr 9;18(6):952-5. doi: 10.1097/00002030-200404090-00016.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active
  • Atazanavir Sulfate
  • Female
  • HIV Protease Inhibitors / therapeutic use*
  • HIV-1*
  • HIV-Associated Lipodystrophy Syndrome / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Oligopeptides / therapeutic use*
  • Pyridines / therapeutic use*

Substances

  • HIV Protease Inhibitors
  • Oligopeptides
  • Pyridines
  • Atazanavir Sulfate